Browsing Tag
Indian pharmaceutical market
2 posts
NATCO Pharma (NSE: NATCOPHARM) launches cheapest semaglutide in India at Rs 1,290 on Day 1 of patent expiry
NATCO Pharma launches generic semaglutide in India at INR 1,290 on Day 1 of patent expiry. What it means for GLP-1 markets. Read the full analysis.
March 20, 2026
Torrent Pharmaceuticals licenses Vonoprazan from Takeda to treat GERD in India
Torrent Pharmaceuticals Limited has secured a non-exclusive patent licensing agreement with Takeda Pharmaceutical Company Limited to commercialize Vonoprazan,…
June 6, 2024